Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34652968

Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2021 Dec 20
First author
Leavey PJ

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 May 1;40(13):1506. doi: 10.1200/JCO.21.02546.
    note
    Source null
    related pmid
    35235371
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2022 May 1;40(13):1507-1508. doi: 10.1200/JCO.21.02922.
    note
    Source null
    related pmid
    35235382
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2022 Jul 20;40(21):2393. doi: 10.1200/JCO.22.01234.
    note
    Source null
    related pmid
    35839523
    relationship
    Erratum in

Authors and identifiers

  1. name
    Leavey PJ
    type
    Author
  2. name
    Laack NN
    type
    Author
  3. name
    Krailo MD
    type
    Author
  4. name
    Buxton A
    type
    Author
  5. name
    Randall RL
    type
    Author
  6. name
    DuBois SG
    type
    Author
  7. name
    Reed DR
    type
    Author
  8. name
    Grier HE
    type
    Author
  9. name
    Hawkins DS
    type
    Author
  10. name
    Pawel B
    type
    Author
  11. name
    Nadel H
    type
    Author
  12. name
    Womer RB
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Leavey PJ
    type
    Author
  2. name
    Laack NN
    type
    Author
  3. name
    Krailo MD
    type
    Author
  4. name
    Buxton A
    type
    Author
  5. name
    Randall RL
    type
    Author
  6. name
    DuBois SG
    type
    Author
  7. name
    Reed DR
    type
    Author
  8. name
    Grier HE
    type
    Author
  9. name
    Hawkins DS
    type
    Author
  10. name
    Pawel B
    type
    Author
  11. name
    Nadel H
    type
    Author
  12. name
    Womer RB
    type
    Author
bibliography ids
  1. nci-bib-af3f277bd6490392f7b739e9
book metadata
content sha256
3cd80c573d9958da22ac7a73a61b11aaa951906844e01cdfe3a191df6346b046
document type
citation
dois
  1. 10.1200/JCO.21.00358
electronic publication date
display
2021 Oct 15
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34652968
immutable id
pubmed:34652968@3cd80c573d9958da22ac7a73a61b11aaa951906844e01cdfe3a191df6346b046
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
36
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
4029-4038
volume
39
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2022 May 1;40(13):1506. doi: 10.1200/JCO.21.02546.
    note
    Source null
    related pmid
    35235371
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2022 May 1;40(13):1507-1508. doi: 10.1200/JCO.21.02922.
    note
    Source null
    related pmid
    35235382
    relationship
    Comment in
  3. citation
    J Clin Oncol. 2022 Jul 20;40(21):2393. doi: 10.1200/JCO.22.01234.
    note
    Source null
    related pmid
    35839523
    relationship
    Erratum in
outcomes validated
false
pmid
34652968
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
a033e1e964ee364ecf376fdcbfe22fd0b56fdb29daecbfa0bdc5d89c893731ec
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Dec 20
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, N.I.H., Extramural
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34652968/
title
Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.

Preserved source evidence · Not medical advice